{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:04:26Z","timestamp":1790370266966,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["115-2320-B-006 -035 -MY3"],"award-info":[{"award-number":["115-2320-B-006 -035 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2320-B-006 -022"],"award-info":[{"award-number":["114-2320-B-006 -022"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e00970","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:06:44Z","timestamp":1786025204000},"page":"e00970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wild-type C9orf72 drives proteasomal dysfunction and mutant aggregates via a Stat1-Isg15 axis in Huntington\u2019s disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Siew Chin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yu","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ying","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Mu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Hsun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12929-021-00755-1","article-title":"The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington\u2019s disease","volume":"28","author":"Tung","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.neurot.2026.e00970_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/7854_2010_105","article-title":"Transgenic animal models of Huntington\u2019s disease","volume":"7","author":"Yang","year":"2011","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13578-025-01452-4","article-title":"Insulin-like growth factor 2 reduces Huntington\u2019s disease aggregates via AKT and NF-\u03baB signaling in Huntington\u2019s disease","volume":"15","author":"Tung","year":"2025","journal-title":"Cell Biosci"},{"issue":"Pt 2","key":"10.1016\/j.neurot.2026.e00970_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2023.10.407","article-title":"miR-196a provides antioxidative neuroprotection via USP15\/Nrf2 regulation in Huntington\u2019s disease","volume":"209","author":"Chan","year":"2023","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00970_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073845","article-title":"Huntington\u2019s disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00429-012-0401-x","article-title":"Significantly differential diffusion of neuropathological aggregates in the brain of transgenic mice carrying N-terminal mutant huntingtin fused with green fluorescent protein","volume":"218","author":"Cheng","year":"2013","journal-title":"Brain Struct Funct"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymeth.2009.05.007","article-title":"Generation of transgenic monkeys with human inherited genetic disease","volume":"49","author":"Chan","year":"2009","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00970_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bpa.12191","article-title":"The differential profiling of ubiquitin-proteasome and autophagy systems in different tissues before the onset of Huntington\u2019s disease models","volume":"25","author":"Her","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neurot.2026.e00970_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnagi.2016.00303","article-title":"Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases","volume":"8","author":"Zheng","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00970_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","article-title":"miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models","volume":"93","author":"Cheng","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00970_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-020-02214-x","article-title":"C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS\/FTD?","volume":"140","author":"Braems","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00970_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.15255","article-title":"Cellular and physiological functions of C9ORF72 and implications for ALS\/FTD","volume":"157","author":"Pang","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2026.e00970_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661447","article-title":"C9ORF72: what it Is, what it does, and why it matters","volume":"15","author":"Smeyers","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00970_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib15","doi-asserted-by":"crossref","first-page":"547 e13","DOI":"10.1016\/j.neurobiolaging.2014.08.020","article-title":"C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population","volume":"36","author":"Koutsis","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00970_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0000000000000061","article-title":"C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies","volume":"82","author":"Hensman Moss","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00970_bib17","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s12276-022-00872-3","article-title":"The diverse repertoire of ISG15: more intricate than initially thought","volume":"54","author":"Kang","year":"2022","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016422","article-title":"A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway","volume":"6","author":"Wood","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00970_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/glia.21167","article-title":"Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model","volume":"59","author":"Wang","year":"2011","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42003-024-06066-z","article-title":"Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage","volume":"7","author":"Homma","year":"2024","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75431-z","article-title":"A meta-analysis of bulk RNA-seq datasets identifies potential biomarkers and repurposable therapeutics against Alzheimer\u2019s disease","volume":"14","author":"Lamisa","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00970_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70091","article-title":"Exploring cordycepin as a neuroprotective agent in Huntington\u2019s disease: in vitro and in vivo insights","volume":"13","author":"Tung","year":"2025","journal-title":"Pharmacol Res Perspect"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00970_bib23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.theriogenology.2016.04.088","article-title":"Lentiviral transgenesis in mice via a simple method of viral concentration","volume":"86","author":"Cheng","year":"2016","journal-title":"Theriogenology"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00970_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/dvg.20289","article-title":"Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus","volume":"45","author":"Yang","year":"2007","journal-title":"Genesis"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00970_bib25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.7150\/thno.18813","article-title":"miR-196a enhances neuronal morphology through suppressing RANBP10 to provide neuroprotection in Huntington\u2019s disease","volume":"7","author":"Her","year":"2017","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00970_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2026.e00928","article-title":"Rad23b exacerbates pathological aggregates through disrupting proteasome functions in Spinocerebellar ataxia type 3","volume":"23","author":"Chen","year":"2026","journal-title":"Neurotherapeutics"},{"issue":"5-6","key":"10.1016\/j.neurot.2026.e00970_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000492499","article-title":"C9orf72 repeat expansion frequency among patients with Huntington disease genetic testing","volume":"18","author":"Ida","year":"2018","journal-title":"Neurodegener Dis"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00970_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00970_bib29","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1093\/nar\/gku485","article-title":"Silencing of IFN-stimulated gene transcription is regulated by histone H1 and its chaperone TAF-I","volume":"42","author":"Kadota","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00970_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112580","article-title":"Targeting MUC1-C suppresses chronic activation of cytosolic nucleotide receptors and STING in triple-negative breast cancer","volume":"14","author":"Yamashita","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00970_bib31","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1080\/15548627.2021.1872189","article-title":"C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels","volume":"17","author":"Beckers","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.neurot.2026.e00970_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1086895","article-title":"Autophagy and neurodegeneration: unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology","volume":"17","author":"Diab","year":"2023","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00970_bib33","first-page":"91","article-title":"Hydrogen sulfide inhibits ferritinophagy-mediated ferroptosis in the hippocampus of rotenone-exposed rats","volume":"68","author":"Chen","year":"2025","journal-title":"J Physiol Invest"},{"key":"10.1016\/j.neurot.2026.e00970_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118952","article-title":"FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington\u2019s disease cells","volume":"267","author":"Yusuf","year":"2021","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00970_bib35","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s12035-020-02220-w","article-title":"Fibroblast growth factor 9 stimulates neuronal length through NF-kB signaling in striatal cell Huntington\u2019s disease models","volume":"58","author":"Yusuf","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00970_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000491889","article-title":"Fibroblast growth factor 9 suppresses striatal cell death dominantly through ERK signaling in Huntington\u2019s disease","volume":"48","author":"Yusuf","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41443-4","article-title":"Variability in donor leukocyte counts confound the use of common RNA sequencing data normalization strategies in transcriptomic biomarker studies performed with whole blood","volume":"13","author":"O\u2019Connell","year":"2023","journal-title":"Sci Rep"},{"issue":"6279","key":"10.1016\/j.neurot.2026.e00970_bib38","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O\u2019Rourke","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.55782\/ane-2022-007","article-title":"Overexpression of C9orf72 exacerbates Abeta25-35-induced oxidative stress and apoptosis in PC12 cells","volume":"82","author":"Chen","year":"2022","journal-title":"Acta Neurobiol Exp"},{"key":"10.1016\/j.neurot.2026.e00970_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137887","article-title":"miR-142-3p alleviates neuronal apoptosis in Parkinson\u2019s disease via negatively regulating C9orf72","volume":"836","author":"Meng","year":"2024","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00970_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-019-02045-5","article-title":"C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy","volume":"138","author":"Cali","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00970_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","article-title":"C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab"},{"issue":"7823","key":"10.1016\/j.neurot.2026.e00970_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","article-title":"C9orf72 in myeloid cells suppresses STING-induced inflammation","volume":"585","author":"McCauley","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/gtc.13188","article-title":"Interferon-Dependent expression of the Human STAT1 gene requires a distal regulatory Region located approximately 6 kb upstream for its autoregulatory system","volume":"30","author":"Yuasa","year":"2025","journal-title":"Genes Cells"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00970_bib45","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/acer.13226","article-title":"Acetaldehyde disrupts interferon alpha signaling in hepatitis C virus-infected liver cells by Up-Regulating USP18","volume":"40","author":"Ganesan","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00970_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106579","article-title":"C9ORF72 suppresses JAK-STAT mediated inflammation","volume":"26","author":"Pang","year":"2023","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00970_bib48","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/0008-5472.CAN-05-1123","article-title":"Elevated expression of ISG15 in tumor cells interferes with the ubiquitin\/26S proteasome pathway","volume":"66","author":"Desai","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2026.e00970_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/srep12704","article-title":"Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis","volume":"5","author":"Fan","year":"2015","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.neurot.2026.e00970_bib50","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1074\/jbc.C800030200","article-title":"ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response","volume":"283","author":"Malakhova","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2005.08.034","article-title":"ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity","volume":"336","author":"Takeuchi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00970_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbrc.2005.08.038","article-title":"ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin","volume":"336","author":"Zou","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00970_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/15548627.2015.1023982","article-title":"Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN\/interferon","volume":"11","author":"Xu","year":"2015","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00970_bib54","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1074\/jbc.M114.593871","article-title":"Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1\/p62","volume":"290","author":"Nakashima","year":"2015","journal-title":"J Biol Chem"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:35:51Z","timestamp":1790368551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926001406"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00970","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wild-type C9orf72 drives proteasomal dysfunction and mutant aggregates via a Stat1-Isg15 axis in Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00970"}}